MyFinsight
Home
About
Contact
atxs: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ATXS has $271,866K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
271,866
281,924
Total stockholders' equity
233,253
260,513
Total liabilities and stockholders' equity
271,866
281,924
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$8,582K
Accounts receivable
$17,243K
Short-term investments
$131,441K
Cash and cash
equivalents
$96,280K
Other assets
$14,066K
Right-of-use asset
$4,254K
Total current assets
$253,546K
Total assets
$271,866K
Total liabilities and
stockholders' equity
$271,866K
Total stockholders'
equity
$233,253K
Total liabilities
$38,613K
Accumulated deficit
-$773,198K
Accumulated other
comprehensive gain
$56K
Additional paid-in capital
$911,014K
Deferred revenue, net of
current portion
$12,041K
Operating lease
liabilities, net of current...
$3,055K
Total current
liabilities
$23,517K
Common stock, 0.001 par
value per share,...
$57K
Preferred stock-Series
XRedeemable Convertible...
$95,324K
Deferred revenue,
current
$4,495K
Operating lease
liabilities, current
$1,404K
Accrued expenses
$16,481K
Accounts payable
$1,137K
Buy me a coffee
Astria Therapeutics, Inc. (ATXS)
Astria Therapeutics, Inc. (ATXS)